Profil
Alex Waldron served as the Chief Executive Officer & Director at Wellinks, Inc. from 2021 to 2023.
Prior to that, he was the Chief Executive Officer at Convexity Scientific, Inc. He also held the position of Chief Strategy Officer at Pear Therapeutics (US), Inc.
Anciens postes connus de Alex Waldron
| Sociétés | Poste | Fin |
|---|---|---|
Wellinks, Inc.
Wellinks, Inc. Medical/Nursing ServicesHealth Services Provides virtual-led cardiopulmonary care through data collection, analysis and intervention software solutions | Directeur Général | 13/07/2023 |
Convexity Scientific, Inc.
Convexity Scientific, Inc. Medical/Nursing ServicesHealth Services Provides chronic obstructive pulmonary disease care services | Directeur Général | 01/03/2023 |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications | Technology Services |
Wellinks, Inc.
Wellinks, Inc. Medical/Nursing ServicesHealth Services Provides virtual-led cardiopulmonary care through data collection, analysis and intervention software solutions | Health Services |
Convexity Scientific, Inc.
Convexity Scientific, Inc. Medical/Nursing ServicesHealth Services Provides chronic obstructive pulmonary disease care services | Health Services |
















